Pyros Pharmaceuticals

Pyros Pharmaceuticals company information, Employees & Contact Information

Updated May 2026

Quick answer

Pyros Pharmaceuticals is a Pharmaceutical Manufacturing company and founded in 2017. It has approximately 15 employees on record. Contact data was last refreshed in May 2026. Find Pyros Pharmaceuticals's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Pyros Pharmaceuticals is a specialty pharmaceutical company focused on developing medicines for rare pediatric diseases and underserved patient populations. We explore a broad range of therapeutic areas that have technically challenging drug delivery mechanisms or other niche applications. Our goal is to provide high-quality, affordable and accessible alternatives for patients that need them the most.

Company Details

Employees
15
Founded
-
Address
2001 Us-46,
Phone
201-743-9468
Email
bd****@****ma.com.
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Parsippany, New Jersey
Looking for a particular Pyros Pharmaceuticals employee's phone or email?

Pyros Pharmaceuticals Questions

News

Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution) - Business Wire

Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution) Business Wire

Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals - PR Newswire

Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals PR Newswire

Pyros Pharmaceuticals Announces VIGPODER™ (vigabatrin) is Now Available - Business Wire

Pyros Pharmaceuticals Announces VIGPODER™ (vigabatrin) is Now Available Business Wire

Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™ (vigabatrin) as the First and Only Ready-to-Use Vigabatrin Oral Solution - Business Wire

Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™ (vigabatrin) as the First and Only Ready-to-Use Vigabatrin Oral Solution Business Wire

Pyros Pharmaceuticals Announces VIGAFYDE™ (vigabatrin), the First and Only Ready-to-Use Vigabatrin Oral Solution, is Now Available - Business Wire

Pyros Pharmaceuticals Announces VIGAFYDE™ (vigabatrin), the First and Only Ready-to-Use Vigabatrin Oral Solution, is Now Available Business Wire

Top Pyros Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant